Investing Profile

Sigþór Sigmarsson

InvestorAngel
Chairman of the Board at 3Z Pharmaceuticals
London
Photo of Sigþór Sigmarsson, 3Z Pharmaceuticals

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Bain & Company Network
409 CONNECTIONS
Bain & Company Network
409 CONNECTIONS
Nova Network
12 CONNECTIONS
cb
$5K - $50K
$25K
4
CompanyStageDateRound SizeTotal Raised
Meniga
Series DDec 2023$16M
$20M
Co-investors: Ruth Foxe Blader (Anthemis Group)
Genis
Series UnknownDec 2022$17M
$17M
Treble
SeedOct 2021$2M
$14M
Co-investors: Sebastian Peck (Kompas VC)
3Z Pharmaceuticals
SeedJul 2016$400K
$400K
Board Member Genís2022 - Present
Board Member indó iceland2022 - Present
Board Member Treble Technologies2021 - Present
Chairman of the Board MF2 Mezzanine Fund2020 - Present
Chairman of the Board 3Z Pharmaceuticals2012 - Present
Executive Director ÍslandsbankiPresent
Chairman of the Board NovaPresent
Chairman of the Board Nova ÍslandPresent
Board Member Gagnavarslan ehf.Present
Head of investment committee Ísafold Capital PartnersPresent
Chairman of the Board indó icelandPresent
General Manager Bain & CompanyPresent
Owner Bain & CompanyPresent
Board Member APRÓPresent
Board Member MenigaPresent
Finance director Novator Partners Llp2006 - 2022
Chairman of the Board NOVA2007 - 2021
Board member Greenqloud2015 - 2017
Chairman of the Board MF1 Mezzanine Credit Fund2015 - 2017
Board Member Azazo2015 - 2016
Executive Director Íslandsbanki / Glitnir1998 - 2006
Háskóli Íslands C.Sc
Sign in with Google →
Sign in with Google →